Facio-therapies recently announced a breakthrough development in FSHD drug discovery. What is it? Facio-therapies have developed a high through-put screening platform that uses muscle cells from people with FSHD and actually measures DUX4 protein levels. Why is it a breakthrough? Most screening platforms use cells that are not specific [...]